Their previous experimental studies demonstrated that L-IFPTA + vaccine-mediated inhibition of PCSK9 moderately suppresses tumor growth and improves lifespan and survival in mice with breast and colon cancers [60, 61]. Here, PCSK9 is linked to neoplasm.